Diabetic foot infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases

Diabetes Care

Volumn 19, Issue 6, 1996, Pages 638-641

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Nesbit, Catherine A ^a  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CEFPROZIL; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN; LORACARBEF; METICILLIN; OFLOXACIN; SPARFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; DIABETIC FOOT; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0029927322     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.6.638     Document Type: Article

References (21)

1. Hamman RF, Michael SL, Keefer SM, Young WF: Impact of policy and procedure changes on hospital days among diabetic nursing home residents: Colorado. Morb Mortal Wkly Rep 33:621-629, 1984
2. Bailey TS, Yu HM, Rayfield EJ: Patterns of foot examination in a diabetic clinic. Am J Med 78:371-374, 1985
3. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1684, 1993
4. Moss SE, Klein R, Klein BEK: The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 152:610-616, 1992
5. Reiber GE, Pecoraro RE, Koepsell TD: Risk for amputation in patients with diabetes mellitus: a case control study. Ann InternMed 117:97-105, 1992
6. Bamberger DM, Daus GP, Gerding DN: Osteomyelitis in the foot of diabetic patients: long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83:653-660, 1987
7. Fierer J, Daniel D, Davis C: The fetid foot: lower-extremity infections in patients with diabetes mellitus. Rev Infect Dis 1:210-217, 1979
8. Hughes CE, Johnson CC, Bamburger DM, Reinhardt JF, Peterson LR, Mulligan ME, Gerding DN, George WM, Finegold SM: Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther 10 (Suppl. A):36-49, 1987
9. Louie TJ, Bartlett JG, Tally FP, Gorbach SL: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85:461-463, 1976
10. Sapico FL, Canawati HN, Witte JL, Montgomerie JZ, Wagner FW Jr, Bessman AN: Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol 12:413-420, 1980
11. Sapico FL, Whitte JN, Canawati HN, Montgomery JZ, Bessman AN: The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 6 (Suppl. 1): 171-176, 1984
12. Wheat LJ, Allen SD, Henry M, Kernek CB, Siders JA, Kuebler T, Fineberg N, Norton J: Diabetic foot infections: bacteriologic analysis. Arch Intern Med 146:1935-1940, 1986
13. Goldstein EJC: Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States. Clin Infect Dis 16 (Suppl. 4):377-381, 1993
14. Barry AL, Fuchs PC: In vitro activities of sparfloxadn, tosufloxacin, ciprofloxacin and fleroxacin. Antimicrob Agents Chemother 35:955-960, 1991
15. Goldstein EJC, Citron DM: Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria. Antimicrob Agents Chemother 36:1158-1162, 1992
16. Neu HC, Chin NX: In vitro activity of sofloxacin. Antimicrob Agents Chemother 33:1105-1107, 1989
17. Une T, Fujimoto T, Sato K, Osada Y: In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother 32:1336-1340, 1988
18. Balows A, Hausler WJ Jr, Herrmann EL, Isenberg HD, Shadomy HJ: Manual of Clinical Microbiology. 5th ed. Washington, DC, American Society for Microbiology, 1991
19. Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, Finegold SM: Wadsworth Anaerobic Bacteriology Manual. 5th ed. Belmont, CA, Star Publishing, 1993
20. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW: Assessment and management of foot disease in patients with diabetes. N Engl J Med 331: 854-860, 1994
21. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH: Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch Intern Med 150:790-797, 1990